IGM Biosciences, Inc. (DELISTED) (IGMS:DL)
1.27
0.00 (0.00%)
USD |
NASDAQ |
Aug 22, 16:00
IGM Biosciences Enterprise Value: -27.73M for Aug. 22, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.532B |
| Tango Therapeutics, Inc. | 1.087B |
| NovaBay Pharmaceuticals, Inc. | 401.17M |
| Theriva Biologics, Inc. | 2.211M |
| Oragenics, Inc. | -10.33M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 97.58M |
| Revenue (Quarterly) | 143.62M |
| Total Expenses (Quarterly) | 46.04M |
| EPS Diluted (Quarterly) | 1.580 |
| Gross Profit Margin (Quarterly) | 99.69% |
| Profit Margin (Quarterly) | 67.94% |
| Operating Earnings Yield | 13.07% |
| Normalized Earnings Yield | -71.78 |